These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31879819)

  • 21. Characterization of Initial Stages of Diabetic Macular Edema.
    Santos AR; Santos T; Alves D; Marques IP; Lobo C; Cunha-Vaz J
    Ophthalmic Res; 2019; 62(4):203-210. PubMed ID: 31013506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
    Browning DJ; Fraser CM; Powers ME
    Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EXTREME DIURNAL VARIATION OF CENTRAL MACULAR THICKNESS IN DIABETIC MACULAR EDEMA.
    Sambhav K; Grover S; Chalam KV
    Retin Cases Brief Rep; 2019; 13(4):324-326. PubMed ID: 28333856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.
    ; Browning DJ; Glassman AR; Aiello LP; Beck RW; Brown DM; Fong DS; Bressler NM; Danis RP; Kinyoun JL; Nguyen QD; Bhavsar AR; Gottlieb J; Pieramici DJ; Rauser ME; Apte RS; Lim JI; Miskala PH
    Ophthalmology; 2007 Mar; 114(3):525-36. PubMed ID: 17123615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.
    ; Krzystolik MG; Strauber SF; Aiello LP; Beck RW; Berger BB; Bressler NM; Browning DJ; Chambers RB; Danis RP; Davis MD; Glassman AR; Gonzalez VH; Greenberg PB; Gross JG; Kim JE; Kollman C
    Ophthalmology; 2007 Aug; 114(8):1520-5. PubMed ID: 17353052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.
    Hillier RJ; Ojaimi E; Wong DT; Mak MYK; Berger AR; Kohly RP; Kertes PJ; Forooghian F; Boyd SR; Eng K; Altomare F; Giavedoni LR; Nisenbaum R; Muni RH
    JAMA Ophthalmol; 2018 Apr; 136(4):382-388. PubMed ID: 29522144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OCT-Leakage: A New Method to Identify and Locate Abnormal Fluid Accumulation in Diabetic Retinal Edema.
    Cunha-Vaz J; Santos T; Ribeiro L; Alves D; Marques I; Goldberg M
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6776-6783. PubMed ID: 27978559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal thickness measurement and evaluation of natural history of the diabetic macular edema through optical coherence tomography.
    Hannouche RZ; Avila MP
    Arq Bras Oftalmol; 2009; 72(4):433-8. PubMed ID: 19820779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Retinal Layer Thickness in Eyes with Resolved Diabetic Macular Edema Receiving Ranibizumab with Normal Eyes.
    Rentiya ZS; Kherani S; Usmani B; Qazi MA; Sadiq MA; Iftikhar M; Nguyen QD; Shah SM; Sepah YJ;
    Ophthalmologica; 2020; 243(1):27-36. PubMed ID: 31747663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitrectomy in the management of diabetic macular edema in treatment-naïve patients.
    Michalewska Z; Stewart MW; Landers MB; Bednarski M; Adelman RA; Nawrocki J
    Can J Ophthalmol; 2018 Aug; 53(4):402-407. PubMed ID: 30119796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
    Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeatability of Spectralis OCT measurements of macular thickness and volume in diabetic macular edema.
    Comyn O; Heng LZ; Ikeji F; Bibi K; Hykin PG; Bainbridge JW; Patel PJ
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7754-9. PubMed ID: 23111610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
    Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
    Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of photoreceptors in eyes with diabetic macular edema.
    Muftuoglu IK; Unsal E; Ozturker ZK
    Eur J Ophthalmol; 2017 Aug; 27(5):585-590. PubMed ID: 28127732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
    Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
    Bressler SB; Ayala AR; Bressler NM; Melia M; Qin H; Ferris FL; Flaxel CJ; Friedman SM; Glassman AR; Jampol LM; Rauser ME;
    JAMA Ophthalmol; 2016 Mar; 134(3):278-85. PubMed ID: 26746868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Insights Into Microaneurysms in the Deep Capillary Plexus Detected by Optical Coherence Tomography Angiography in Diabetic Macular Edema.
    Hasegawa N; Nozaki M; Takase N; Yoshida M; Ogura Y
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT348-55. PubMed ID: 27409492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Ultra-Widefield Angiographic Features and Associations with Diabetic Macular Edema.
    Jiang AC; Srivastava SK; Hu M; Figueiredo N; Babiuch A; Boss JD; Reese JL; Ehlers JP
    Ophthalmol Retina; 2020 Jan; 4(1):49-56. PubMed ID: 31690541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes.
    Bahrami B; Hong T; Schlub TE; Chang AA
    Retina; 2019 Jan; 39(1):61-68. PubMed ID: 30015767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.